Price
CHART BY
Frequently asked questions
What is Bio Rad's market capitalization?
What is Bio Rad's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Bio Rad?
What are the analyst ratings and target price for Bio Rad's stock?
What is Bio Rad's revenue over the trailing twelve months?
What is the EBITDA for Bio Rad?
What is the free cash flow of Bio Rad?
How many employees does Bio Rad have, and what sector and industry does it belong to?
What is the free float of Bio Rad's shares?
Financials
- Market Cap
- $7.53B
- EPS (TTM)
- $27.92
- Free Float
- 18.09M
- P/E ratio (TTM)
- 10.02
- Revenue (TTM)
- $2.58B
- EBITDA (TTM)
- $470.10M
- Free Cashflow (TTM)
- $374.60M
Pricing
- 1D span
- $265.30$273.79
- 52W span
- $213.25$342.30
Analyst Ratings
The price target is $335.00 and the stock is covered by 8 analysts.
Buy
4
Hold
4
Sell
0
Information
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
- Employees
- 7,450
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- BIO